These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 34444990)

  • 1. Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases.
    Guerra JVS; Dias MMG; Brilhante AJVC; Terra MF; García-Arévalo M; Figueira ACM
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
    Palmer K; Monaco A; Kivipelto M; Onder G; Maggi S; Michel JP; Prieto R; Sykara G; Donde S
    Aging Clin Exp Res; 2020 Jul; 32(7):1189-1194. PubMed ID: 32458356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic non-communicable diseases in the epidemic (COVID-19): Investigation of risk factors, control and care.
    Aleebrahim-Dehkordi E; Deravi N; Reyhanian A; Saberianpour S; Mokhtari M; Hasanpour-Dehkordi A
    Przegl Epidemiol; 2020; 74(3):449-456. PubMed ID: 33570342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolevel association of COVID-19 with non-communicable disease risk factors in India.
    Gaur K; Khedar RS; Mangal K; Sharma AK; Dhamija RK; Gupta R
    Diabetes Metab Syndr; 2021; 15(1):343-350. PubMed ID: 33503583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
    Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH
    Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
    Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
    Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity?
    Bello B; Useh U
    Am J Health Promot; 2021 Jun; 35(5):720-729. PubMed ID: 33576237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk, burden, and management of non-communicable diseases in cerebral palsy: a scoping review.
    Ryan JM; Allen E; Gormley J; Hurvitz EA; Peterson MD
    Dev Med Child Neurol; 2018 Aug; 60(8):753-764. PubMed ID: 29572812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis.
    Pan L; Huang P; Xie X; Xu J; Guo D; Jiang Y
    Dig Liver Dis; 2021 Feb; 53(2):153-157. PubMed ID: 33011088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB
    Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.
    Lamadrid P; Alonso-Peña M; San Segundo D; Arias-Loste M; Crespo J; Lopez-Hoyos M
    Front Immunol; 2021; 12():651728. PubMed ID: 33859644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of behavioural risk factors on communicable diseases: a systematic review of reviews.
    Wood S; Harrison SE; Judd N; Bellis MA; Hughes K; Jones A
    BMC Public Health; 2021 Nov; 21(1):2110. PubMed ID: 34789209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital Health Tools for Managing Noncommunicable Diseases During and After the COVID-19 Pandemic: Perspectives of Patients and Caregivers.
    Monaco A; Palmer K; Holm Ravn Faber N; Kohler I; Silva M; Vatland A; van Griensven J; Votta M; Walsh D; Clay V; Yazicioglu MC; Ducinskiene D; Donde S
    J Med Internet Res; 2021 Jan; 23(1):e25652. PubMed ID: 33464206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of food insecurity and malnutrition on the burden of Non-communicable diseases and death in Ethiopia: A situational analysis.
    Mosadeghrad AM; Gebru AA; Sari AA; Tafesse TB
    Hum Antibodies; 2019; 27(4):213-220. PubMed ID: 30958340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review.
    Chang AY; Cullen MR; Harrington RA; Barry M
    J Intern Med; 2021 Apr; 289(4):450-462. PubMed ID: 33020988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.
    Vasques-Monteiro IML; Souza-Mello V
    World J Gastroenterol; 2021 Apr; 27(16):1738-1750. PubMed ID: 33967554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressure injury: A non-negligible comorbidity for critical Covid-19 patients.
    Yu N; Li Z; Long X; Huang J; Cao W; Zhang Y; Yang Y; Liu Z; Liu Z; Zhang S; Wang X
    J Plast Reconstr Aesthet Surg; 2021 Mar; 74(3):644-710. PubMed ID: 32828699
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19).
    Khunti S; Khunti N; Seidu S; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1942-1945. PubMed ID: 32319200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, adaptative immune response and metabolic-associated liver disease.
    Miele L; Napodano C; Cesario A; De Magistris A; Pocino K; Basile U; Rapaccini GL; Gasbarrini A; Grieco A
    Liver Int; 2021 Nov; 41(11):2560-2577. PubMed ID: 34555255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.